S. Toulmond

R. P. Stroemer, C. Davies, S. Loddick, 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

A Caspase Active Site Probe Reveals High Fractional Inhibition Needed to Block DNA Fragmentation*

N. Méthot, Yongxin Han, R. Zamboni, 2004, Journal of Biological Chemistry.

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window

J. Bénavidès, B. Scatton, S. Toulmond, 1993, Brain Research.

The interleukin-1 type I receptor is expressed in human hypothalamus.

D. Smart, J. Hughes, S. Toulmond, 1999, Brain : a journal of neurology.

Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide.

J. Bénavidès, B. Scatton, S. Toulmond, 1991, Brain research.

Design and synthesis of potent, isoxazole-containing renin inhibitors.

J. Falgueyret, M. Percival, Yongxin Han, 2012, Bioorganic & medicinal chemistry letters.

Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.

J. Falgueyret, M. Percival, Yongxin Han, 2011, Bioorganic & medicinal chemistry letters.

Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.

J. Falgueyret, M. Percival, Yongxin Han, 2011, Bioorganic & medicinal chemistry letters.

Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.

C. Bayly, S. Gagné, S. Soisson, 2010, Bioorganic & medicinal chemistry letters.

The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.

N. Rothwell, S. Allan, S. Toulmond, 1997, The Journal of clinical investigation.

Differential Efficacy of Caspase Inhibitors on Apoptosis Markers during Sepsis in Rats and Implication for Fractional Inhibition Requirements for Therapeutics

N. Méthot, Yongxin Han, R. Zamboni, 2004, The Journal of experimental medicine.

When cytokines get on your nerves: cytokine networks and CNS pathologies

P. Parnet, S. Toulmond, A. Linthorst, 1996, Trends in Neurosciences.

Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.

J. Falgueyret, M. Percival, R. Oballa, 2005, Journal of medicinal chemistry.

heart failure and cachexia Cardiac gene expression profile in rats with terminal

M. Lalowski, M. Orešič, M. Baumann, 2015 .

Neuroprotective effects of M826, a reversible caspase‐3 inhibitor, in the rat malonate model of Huntington's disease

G. Robertson, Yongxin Han, M. Rigby, 2004, British journal of pharmacology.

Neuroprotective effects of M 826 , a reversible caspase-3 inhibitor , in the rat malonate model of Huntington ’ s disease

G. Robertson, Yongxin Han, M. Rigby, 2004 .

Biochemical and histological alterations induced by fluid percussion brain injury in the rat

B. Scatton, B. Scatton, S. Toulmond, 1993, Brain Research.

Pharmacological and genetic evidence that cathepsin B is not the physiological activator of rodent prorenin

M. Percival, W. Cromlish, J. Gauthier, 2010, Biological chemistry.

Perspectives Series: Cytokines and The Brain The Role of Interleukin 1 in Acute Neurodegeneration and Stroke: Pathophysiological and Therapeutic Implications

N. Rothwell, S. Toulmond, S. Allan, 2013 .